From BioHealth Investor Shares of Novavax, Inc. (NVAX) shot up almost 10% in after hours trading on Monday as the company announced positive results of its avian flu virus vaccine in animal studies. The…
As Big Pharma companies lose share to generics, Wall St.’s theory is that they should buy smaller companies that are developing new, hot drugs. If Big Pharma can’t fill its pipeline through R&D alone,…
From BioHealth Investor The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative Strength by Investor’s Business Daily (1/20/06) scores out of 100 (last week’s rank, change…
From BioHealth Investor by Adam Rubenstein NovaVision (Boca Raton, FL) a non-invasive device that may restore vision loss in stroke and traumatic brain injury patients has raised $20M in Series C. The deal was…
From BioHealth Investor by Andrew Vaino Javelin Pharmaceuticals (JAV) is a tiny biotech focused on drug delivery. Their lead compound is Dyloject, an injectable form of pain-killer diclofenac. One of the problems with injecting…
From BioHealth Investor by H.S. AyoubBioHealth Investor.com The FDA issued a warning letter to Dr.Alfred T Sapse of Stem Cell Pharma, Inc., a Las Vegas company, alleging that the doctor and the company had…
After Cramer sort of touted WCI Communities (WCI) and told you to put it on a watch list, he discussed a stock that is acting like a winner. Cramer noted that Genentech (DNA) was…
From BioHealth Investor by H.S. AyoubBioHealth Investor.com The Department of Health and Human Services (DHHS) has awarded GlaxoSmithKline (GSK), Novartis Vaccines and Diagnostics (NVS) and Iomi (IOMI) all a total of $133 million in…
From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotech stocks generally did well on Tuesday as the Nasdaq Biotech Index (^NBI) gained 0.11% to 831.94. Cerus (CERS) gained more than 12% after the company received…